What's New


License Agreement Has Been Entered into with T&R Biofab Co., Ltd.

We have executed a non-exclusive license agreement with T&R Biofab Co., Ltd. (Gyeonggi-do, Republic of Korea) for allowing them to provide iPS cell-derived cardiomyocytes for user's research purposes under the patents on iPS cell technologies licensed to us by Kyoto University.

T&R Biofab Co., Ltd.

Back to top